APA (7th ed.) Citation

N, M., K, A., JI, B., N, B., D, B., F, T., . . . P, R. (2022). Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease. Genome medicine, 14(1), 110. https://doi.org/10.1186/s13073-022-01112-z

Chicago Style (17th ed.) Citation

N, Mishra, et al. "Longitudinal Multi-omics Analysis Identifies Early Blood-based Predictors of Anti-TNF Therapy Response in Inflammatory Bowel Disease." Genome Medicine 14, no. 1 (2022): 110. https://doi.org/10.1186/s13073-022-01112-z.

MLA (9th ed.) Citation

N, Mishra, et al. "Longitudinal Multi-omics Analysis Identifies Early Blood-based Predictors of Anti-TNF Therapy Response in Inflammatory Bowel Disease." Genome Medicine, vol. 14, no. 1, 2022, p. 110, https://doi.org/10.1186/s13073-022-01112-z.